CD20 monoclonal antibody-based first-line therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD20 monoclonal antibody-based first-line therapy, covering 2026-03-25 to 2026-03-25. Get the full timeline:
Most recent: Clinical Trial Update: CD20 Monoclonal Antibody-Based First-Line Therapy in Treatment-Naive Marginal Zone B-Cell Lymphoma